Bellinvia, Angelo
Prestipino, Elio
Portaccio, Emilio
Razzolini, Lorenzo
Fonderico, Mattia
Fratangelo, Roberto
Tudisco, Laura
Pastò, Luisa
Amato, Maria P.
Article History
Received: 11 February 2020
Accepted: 16 April 2020
First Online: 29 April 2020
Compliance with ethical standards
:
: MP Amato received research grants and honoraria as a speaker and member of advisory boards from Bayer, Biogen, Merck, Novartis, Sanofi Genzyme, Teva, Almirall, and Roche. E Portaccio served as scientific advisory board for Biogen Idec and Merck Serono; received honoraria for speaking and funding for traveling from Biogen, Genzyme, Novartis, Merck, and Teva; and received research support from Merck Serono. L. Pastò and L. Razzolini received editorial grant from Teva, Almirall, Genzyme, and Merck. All other authors declare that they have no conflict of interest.
: This study was approved by the institutional review board of the University of Florence, Italy, and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all patients.
: The authors declare that neither the article nor portions of it have been previously published elsewhere, that the manuscript is not under consideration for publication in another journal, and will not be submitted elsewhere until the <i>Neurol Sci</i> editorial process is completed. All authors consent for the publication of the manuscript in <i>Neurol Sci</i>, should the article be accepted by the Editor-in-Chief upon completion of the refereeing process.
: Not applicable.